Neoadjuvant Study Investigating Degarelix in Patients Suffering From Prostate Cancer

NCT00833248 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

246

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer

Interventions

DRUG: Degarelix
DRUG: Goserelin
DRUG: Bicalutamide

Sponsor

Ferring Pharmaceuticals